Payment overview · 2025
General Payments
$13.89
1 reported records · 1 companies
Healthcare provider profile · identity verified
Sean Stuart Stout, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · PUYALLUP, WA · NPI 1316925498
Verified facts
What the public records show
CMS Open Payments records show Sean Stuart Stout, M.D. received $13.89 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported OTEZLA as an associated drug or biological on 177267 records involving 48600 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Otezla by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $13.89 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $13.89 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | OTEZLA open payments reported associated product |
CMS Open Payments — General Payments 177267 supporting records · 48600 recipient NPIs · example record 1226871616 |
Otezla · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 626 | 176 |
| Levothyroxine Sodium | Levothyroxine Sodium | 466 | 120 |
| Lisinopril | Lisinopril | 341 | 100 |
| Amlodipine Besylate | Amlodipine Besylate | 299 | 86 |
| Oxycodone Hcl | Oxycodone Hcl | 287 | 37 |
| Losartan Potassium | Losartan Potassium | 271 | 78 |
| Omeprazole | Omeprazole | 267 | 73 |
| Metformin Hcl | Metformin Hcl | 262 | 72 |
| Gabapentin | Gabapentin | 257 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 240 | 71 |
| Trazodone Hcl | Trazodone Hcl | 215 | 56 |
| Tizanidine Hcl | Tizanidine Hcl | 192 | 66 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 190 | 36 |
| Sertraline Hcl | Sertraline Hcl | 190 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 187 | 62 |
| Hydrochlorothiazide | Hydrochlorothiazide | 185 | 54 |
| Simvastatin | Simvastatin | 182 | 56 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 156 | 52 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 154 | 65 |
| Duloxetine Hcl | Duloxetine Hcl | 144 | 40 |
| Pantoprazole Sodium | Pantoprazole Sodium | 144 | 41 |
| Furosemide | Furosemide | 143 | 47 |
| Potassium Chloride | Potassium Chloride | 132 | 34 |
| Eliquis | Apixaban | 122 | 35 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 104 | 20 |
| Famotidine | Famotidine | 104 | 28 |
| Tramadol Hcl | Tramadol Hcl | 103 | 22 |
| Lorazepam | Lorazepam | 100 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 93 | 42 |
| Pioglitazone Hcl | Pioglitazone Hcl | 92 | 24 |
| Allopurinol | Allopurinol | 90 | 28 |
| Alendronate Sodium | Alendronate Sodium | 89 | 23 |
| Prednisone | Prednisone | 86 | 50 |
| Xarelto | Rivaroxaban | 85 | 25 |
| Pregabalin | Pregabalin | 82 | 24 |
| Bupropion Hcl Sr | Bupropion Hcl | 81 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 81 | 28 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 81 | 16 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 79 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 79 | 22 |
| Clonazepam | Clonazepam | 77 | 11 |
| Ozempic | Semaglutide | 77 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 77 | 15 |
| Montelukast Sodium | Montelukast Sodium | 76 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 75 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 75 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 74 | 23 |
| Jardiance | Empagliflozin | 72 | 18 |
| Telmisartan | Telmisartan | 72 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 71 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 67 | suppressed |
| Acyclovir | Acyclovir | 66 | 21 |
| Finasteride | Finasteride | 66 | 20 |
| Ondansetron Odt | Ondansetron | 66 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 66 | 16 |
| Buspirone Hcl | Buspirone Hcl | 65 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 65 | 18 |
| Glipizide | Glipizide | 64 | 17 |
| Carvedilol | Carvedilol | 63 | 20 |
| Donepezil Hcl | Donepezil Hcl | 62 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 61 | 17 |
| Metformin Hcl Er | Metformin Hcl | 60 | 24 |
| Topiramate | Topiramate | 59 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 58 | 40 |
| Pravastatin Sodium | Pravastatin Sodium | 57 | 16 |
| Spironolactone | Spironolactone | 53 | 16 |
| Warfarin Sodium | Warfarin Sodium | 53 | 12 |
| Alprazolam | Alprazolam | 51 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 51 | suppressed |
| Mounjaro | Tirzepatide | 49 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 47 | 17 |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 46 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 46 | suppressed |
| Nystatin | Nystatin | 45 | 17 |
| Ipratropium Bromide | Ipratropium Bromide | 44 | 20 |
| Lamotrigine | Lamotrigine | 44 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 43 | 13 |
| Methocarbamol | Methocarbamol | 42 | 12 |
| Naproxen | Naproxen | 40 | 19 |
| Nitroglycerin | Nitroglycerin | 40 | 19 |
| Baclofen | Baclofen | 39 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 39 | suppressed |
| Atenolol | Atenolol | 38 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | suppressed |
| Bupropion Xl | Bupropion Hcl | 37 | 12 |
| Diazepam | Diazepam | 36 | suppressed |
| Lactulose | Lactulose | 36 | 13 |
| Meloxicam | Meloxicam | 36 | 15 |
| Cephalexin | Cephalexin | 35 | 28 |
| Ezetimibe | Ezetimibe | 35 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 34 | suppressed |
| Risperidone | Risperidone | 34 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | 11 |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 33 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 32 | suppressed |
| Fluconazole | Fluconazole | 31 | 14 |
| Gemfibrozil | Gemfibrozil | 30 | suppressed |
| Levetiracetam | Levetiracetam | 30 | suppressed |
| Torsemide | Torsemide | 29 | 12 |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Myrbetriq | Mirabegron | 28 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 28 | suppressed |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Estradiol | Estradiol | 26 | suppressed |
| Glimepiride | Glimepiride | 26 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 25 | 11 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 24 | suppressed |
| Eszopiclone | Eszopiclone | 24 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Lovastatin | Lovastatin | 23 | suppressed |
| Ibuprofen | Ibuprofen | 22 | suppressed |
| Latanoprost | Latanoprost | 22 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 22 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Acarbose | Acarbose | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 17 |
| Azithromycin | Azithromycin | 20 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 19 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 19 | suppressed |
| Memantine Hcl | Memantine Hcl | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Ketoconazole | Ketoconazole | 18 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 18 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 11 |
| Anastrozole | Anastrozole | 17 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Gemtesa | Vibegron | 16 | suppressed |
| Premarin | Estrogens, Conjugated | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 15 | 11 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 14 | suppressed |
| Carisoprodol | Carisoprodol | 14 | suppressed |
| Constulose | Lactulose | 14 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Butalbital-Aspirin-Caffeine | Butalbital/Aspirin/Caffeine | 12 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Endocet | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Otezla | Apremilast | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.89 · 1 records | Amgen Inc. | — | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error